EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19

Mohamed H Abdelazim, Faisal Alsenani, Mohammed Alnuhait, Abdullah S Alshammari, Abdullah H Altemani, Eyad A Althagafi, Dania S Waggas, Ahmed H Abdelazim, Adnan Alharbi

European Archives of Oto-Rhino-Laryngology · 2024

DOI: 10.1007/s00405-024-08802-x ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Archives of Oto-Rhino-Laryngology, 2024. Verfasst von Mohamed H Abdelazim und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Faculty of Medicine, Al-Azhar University, Damietta, Egypt. Hauptthemen laut MEDLINE: Colforsin, COVID-19, Olfaction Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColforsinCOVID-19Olfaction DisordersHumansMaleFemaleMiddle AgedProspective StudiesChronic DiseaseAdultTreatment OutcomeAgedSARS-CoV-2Double-Blind Method

Stichwörter der Autor:innen

Adenylyl cyclaseClinical studyForskolinOlfactory dysfunctionSniffin’ sticks

Substanzen

Colforsin

Autor:innen und Institutionen

  • Department of Otolaryngology, Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
  • Department of Pharmaceutical Sciences, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Pharmaceutical Practices Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
  • Department of Family and Community Medicine, Faculty of Medicine, University of Tabuk, Tabuk, Saudi Arabia.
  • Department of pharmaceutical care, King Fahad General Hospital, Jeddah, Saudi Arabia.
  • Department of Pathological Sciences, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.

Zitieren

APA

Abdelazim, M. H., Alsenani, F., Alnuhait, M., Alshammari, A. S., Altemani, A. H., Althagafi, E. A., Waggas, D. S., Abdelazim, A. H., & Alharbi, A. (2024). Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-024-08802-x

Vancouver

Abdelazim MH, Alsenani F, Alnuhait M, Alshammari AS, Altemani AH, Althagafi EA, et al. Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19. European Archives of Oto-Rhino-Laryngology. 2024. doi:10.1007/s00405-024-08802-x

BibTeX
@article{Abdelazim2024,
  author = {Abdelazim, Mohamed H and Alsenani, Faisal and Alnuhait, Mohammed and Alshammari, Abdullah S and Altemani, Abdullah H and Althagafi, Eyad A and Waggas, Dania S and Abdelazim, Ahmed H and Alharbi, Adnan},
  title = {Efficacy of forskolin as a promising therapy for chronic olfactory dysfunction post COVID-19},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2024},
  doi = {10.1007/s00405-024-08802-x}
}
Kostenlos starten →